09989.HK
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 4.23
−0.59%Leverage
- Debt / equity
- 0.24x
- Net debt / equity
- 0.12x
- Debt / assets
- 0.18x
- Debt / EBITDA
- 8.23x
- Net debt / EBITDA
- 3.91x
Liquidity & coverage
- Current ratio
- 2.31x
- Quick ratio
- 1.33x
- Cash ratio
- 0.89x
- Interest coverage
- 3.36x
- EBITDA / interest
- 6.16x
- Working capital
- HKD 6.1B
Cash & dividend
- FCF / debt
- 0.49x
- Cash flow / debt
- 0.52x
- Dividend per share
- HKD 0.17
- Dividend yield
- 3.9%
- Dividend growth 1y
- -38.9%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026